B.-R. Balda

1.3k total citations
57 papers, 816 citations indexed

About

B.-R. Balda is a scholar working on Oncology, Epidemiology and Dermatology. According to data from OpenAlex, B.-R. Balda has authored 57 papers receiving a total of 816 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 15 papers in Epidemiology and 12 papers in Dermatology. Recurrent topics in B.-R. Balda's work include Cutaneous Melanoma Detection and Management (12 papers), Viral-associated cancers and disorders (10 papers) and Cutaneous lymphoproliferative disorders research (7 papers). B.-R. Balda is often cited by papers focused on Cutaneous Melanoma Detection and Management (12 papers), Viral-associated cancers and disorders (10 papers) and Cutaneous lymphoproliferative disorders research (7 papers). B.-R. Balda collaborates with scholars based in Germany, United States and Ireland. B.-R. Balda's co-authors include Hans Starz, D. Bachter, Harry Vogt, Otto Braun‐Falco, F. Miller, Kerstin Querings, S. Spiegelman, R. Hehlmann, David Y. Rosenzweig and Matthias Möhrle and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Oncology.

In The Last Decade

B.-R. Balda

52 papers receiving 746 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B.-R. Balda Germany 17 467 241 213 146 142 57 816
R.M. MacKie United Kingdom 18 558 1.2× 266 1.1× 237 1.1× 130 0.9× 266 1.9× 37 932
Donato Calista Italy 15 395 0.8× 242 1.0× 340 1.6× 118 0.8× 320 2.3× 46 987
M. Keefe United Kingdom 16 202 0.4× 196 0.8× 227 1.1× 88 0.6× 75 0.5× 33 676
Naotaka Shibagaki Japan 16 278 0.6× 109 0.5× 124 0.6× 372 2.5× 362 2.5× 42 920
W. Lechner Germany 8 419 0.9× 171 0.7× 144 0.7× 92 0.6× 161 1.1× 15 560
H. Kaufmann Germany 6 223 0.5× 161 0.7× 166 0.8× 25 0.2× 90 0.6× 19 667
B. Cooke Australia 12 249 0.5× 216 0.9× 196 0.9× 135 0.9× 178 1.3× 19 680
Herbert Ichinose United States 15 376 0.8× 238 1.0× 208 1.0× 36 0.2× 192 1.4× 25 803
Markus Hantschke Germany 20 611 1.3× 498 2.1× 553 2.6× 136 0.9× 440 3.1× 42 1.6k
Alfred W. Kopf United States 11 560 1.2× 321 1.3× 335 1.6× 62 0.4× 192 1.4× 12 782

Countries citing papers authored by B.-R. Balda

Since Specialization
Citations

This map shows the geographic impact of B.-R. Balda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B.-R. Balda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B.-R. Balda more than expected).

Fields of papers citing papers by B.-R. Balda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B.-R. Balda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B.-R. Balda. The network helps show where B.-R. Balda may publish in the future.

Co-authorship network of co-authors of B.-R. Balda

This figure shows the co-authorship network connecting the top 25 collaborators of B.-R. Balda. A scholar is included among the top collaborators of B.-R. Balda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B.-R. Balda. B.-R. Balda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Querings, Kerstin, Hans Starz, & B.-R. Balda. (2006). Clinical spectrum of cutaneous Langerhans' cell histiocytosis mimicking various diseases. Acta Dermato Venereologica. 86(1). 39–43. 29 indexed citations
2.
Starz, Hans, et al.. (2004). Sentinel lymphonodectomy and S-classification: A successful strategy for better prediction and improvement of outcome of melanoma. Annals of Surgical Oncology. 11(S3). 162S–168S. 99 indexed citations
3.
Uter, Wolfgang, B.-R. Balda, Axel Schnuch, et al.. (2004). The prevalence of contact allergy differed between population-based and clinic-based data. Journal of Clinical Epidemiology. 57(6). 627–632. 31 indexed citations
4.
Starz, Hans, et al.. (2003). Tyrosinase RT-PCR as a Supplement to Histology for Detecting Melanoma and Nevus Cells in Paraffin Sections of Sentinel Lymph Nodes. Modern Pathology. 16(9). 920–929. 23 indexed citations
5.
Querings, Kerstin, D. Bachter, & B.-R. Balda. (2002). Meshed Reversed Dermal Graft in Patients with Surgical Defects of Sole and Scalp: Technique and Long-Term Results. Dermatologic Surgery. 28(2). 122–126. 7 indexed citations
6.
Konstantinow, A., et al.. (2001). Toxische epidermale Nekrolyse (Arzneimittel-induziertes Lyell-Syndrom) - Teil 1: Klinik und Differentialdiagnose¹ -. DMW - Deutsche Medizinische Wochenschrift. 126(6). 141–144.
7.
Konstantinow, A., et al.. (2001). Toxische epidermale Nekrolysen (Arzneimittel-induziertes Lyell-Syndrom). DMW - Deutsche Medizinische Wochenschrift. 126(7). 177–179. 4 indexed citations
8.
Starz, Hans, et al.. (2001). Prognostic and Therapeutic Implications of Sentinel Lymphonodectomy and S-Staging in Merkel Cell Carcinoma. Dermatology. 202(3). 225–229. 30 indexed citations
9.
Bachter, D., et al.. (2001). The Predictive Value of the Sentinel Lymph Node in Malignant Melanomas. Recent results in cancer research. 158. 129–136. 27 indexed citations
11.
Balda, B.-R., et al.. (2000). Guess what! Diagnosis: Extended ulcerating metatypical basal cell carcinoma (BCC) with soft tissue and bone destruction.. PubMed. 10(4). 315–6. 3 indexed citations
12.
Starz, Hans, et al.. (1999). Secondary lymph node involvement from primary cutaneous large B-cell lymphoma of the leg: sentinel lymph nodectomy as a new strategy for staging circumscribed cutaneous lymphomas.. PubMed. 85(1). 199–207. 27 indexed citations
13.
Balda, B.-R., Hendrik Wolf, C. Baumgarten, et al.. (1998). Tree‐pollen allergy is efficiently treated by short‐term immunotherapy (STI) with seven preseasonal injections of molecular standardized allergens. Allergy. 53(8). 740–748. 36 indexed citations
14.
Bachter, D., et al.. (1996). Die „sentinel" Lymphonodektomie mittels Szintillationsdetektor. Der Hautarzt. 47(10). 754–758. 14 indexed citations
15.
Balda, B.-R., et al.. (1975). Oncornavirus-like particles in human skin cancers.. Proceedings of the National Academy of Sciences. 72(9). 3697–3700. 34 indexed citations
16.
Balda, B.-R., et al.. (1972). Zum Stoffwechsel maligner Melanome. Biochemische Untersuchungen.. Archives of Dermatological Research. 244(1). 278–281.
17.
Balda, B.-R., et al.. (1971). Differences in the vitro amino acid labelling pattern of mitochondria from melanoma and liver. FEBS Letters. 15(2). 156–160. 3 indexed citations
18.
Balda, B.-R., et al.. (1970). Proflavine inhibition of protein synthesis in malignant hamster melanoma. FEBS Letters. 11(3). 221–223. 8 indexed citations
19.
Balda, B.-R., et al.. (1970). Der Einflu� von Proflavin auf den DNS-Stoffwechsel des Hamstermelanoms. Archives of Dermatological Research. 239(2). 176–184. 7 indexed citations
20.
Neubert, Diether, et al.. (1968). Biochemical studies on the nucleic acid metabolism of embryonic tissue and the effect of drugs. Naunyn-Schmiedeberg s Archives of Pharmacology. 259(2). 186–188. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026